Cogstate Limited (ASX:CGS – Get Free Report) insider Richard Mohs purchased 13,000 shares of the stock in a transaction dated Wednesday, September 3rd. The stock was purchased at an average cost of A$1.73 per share, for a total transaction of A$22,529.00.
Cogstate Price Performance
The firm has a market capitalization of $206.30 million, a PE ratio of 25.01 and a beta of 0.14. The company has a current ratio of 3.45, a quick ratio of 2.24 and a debt-to-equity ratio of 1.64.
Cogstate Dividend Announcement
The company also recently declared a Final dividend, which will be paid on Sunday, September 28th. Stockholders of record on Sunday, September 28th will be issued a $0.02 dividend. This represents a dividend yield of 112.0%. The ex-dividend date of this dividend is Tuesday, August 26th.
About Cogstate
Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions.
Featured Stories
- Five stocks we like better than Cogstate
- Best Aerospace Stocks Investing
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- About the Markup Calculator
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
- Growth Stocks: What They Are, Examples and How to Invest
- The Quiet Before the Catalyst: Vertical Aerospace’s Next Move
Receive News & Ratings for Cogstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogstate and related companies with MarketBeat.com's FREE daily email newsletter.
